Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
Ultrasound is routinely used to screen for HCC. However, its utility is limited by numerous factors, including patient body habitus, operator experience and certain liver conditions, all of which contribute to decreases in sensitivity.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
Hologic has released its results of its fourth quarter 2005 fiscal year with strong revenue of $78.2 million, a 22 percent rise compared to $63.9 million in the same period in fiscal 2004.
Siemens Medical Solutions and Invivo Corporation recently announced a strategic partnership that will integrate Invivo's computer-aided-detection (CAD) system with Siemens' MAGNETOM magnetic resonance imaging (MRI) systems for advanced breast MRI technolo
iCAD Inc. recently announced the availability of its PureLook Mammography Film Digitizer. PureLook is the film-to-digital acquisition module for the iCAD TotalLook, and SecondLook product lines, the company said.
In a victory for interoperability, Health Level Seven last week announced plans to create an implementation guide for expressing Continuity of Care Record (CCR) patient data -including a summary of a patient's most recent and vital medical information - w
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
